Consolidated Balance Sheets - USD ($)
|
Nov. 30, 2021 |
Nov. 30, 2020 |
| Consolidated Balance Sheets |
|
|
| Cash |
$ 771,945
|
$ 202,046
|
| Assets |
|
|
| Trade and other receivables, net |
0
|
566,384
|
| Investment tax credits |
268,179
|
482,135
|
| Prepaid expenses, sundry and other assets |
62,192
|
115,750
|
| Inventory (Note 3) |
0
|
112,672
|
| Current assets |
1,102,316
|
1,478,987
|
| Property and equipment, net (Note 5) |
994,109
|
1,770,137
|
| Right-of-use asset (Note 9) |
0
|
137,931
|
| Assets |
2,096,425
|
3,387,055
|
| Liabilities |
|
|
| Accounts payable |
3,779,550
|
4,103,966
|
| Accrued liabilities (Note 6) |
2,272,610
|
1,780,272
|
| Employee costs payable (Note 8) |
2,263,944
|
1,665,236
|
| Operating lease liability (Note 9) |
0
|
157,110
|
| Income tax payable (Note 15) |
18,178
|
38,511
|
| Promissory notes payable (Note 7) |
165,878
|
163,758
|
| Convertible debentures (Note 7) |
1,751,483
|
1,791,791
|
| Liabilities |
10,251,643
|
9,700,644
|
| Shareholders' deficiency |
|
|
| Capital stock (Note 10) Authorized: Unlimited common shares without par value, Unlimited preference shares, Issued and outstanding 33,092,665 common shares (November 30, 2020 - 23,678,105) |
49,175,630
|
46,144,402
|
| Additional paid-in capital |
44,626,436
|
44,354,138
|
| Accumulated other comprehensive income |
284,421
|
284,421
|
| Accumulated deficit |
(102,241,705)
|
(97,096,550)
|
| Shareholders' (deficiency)/equity |
(8,155,218)
|
(6,313,589)
|
| Liabilities and shareholders' (deficiency)/equity |
$ 2,096,425
|
$ 3,387,055
|